Hims & Hers Health Stock Takes Hit as Eli Lilly Offers Cheaper Weight-Loss Drug
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1339400988-01160850566a468d80077a40db248953.jpg)
Bryan Bedder / Getty Images for REVOLVE
Key TakeawaysHims & Hers Health shares declined Tuesday after Eli Lilly said it would be offering a lower-priced version of its popular Zepbound weight-loss treatment.Lilly explained that the new product would be sent directly to consumers.Hims & Hers recently began offering a copycat version of Novo Nordisk's Wegovy and Ozempic, and planned to have one for Zepbound in the near future.
Shares of Hims & Hers Health (HIMS) sank in intraday trading Tuesday on new competition for lower-priced weight-loss drugs from Eli Lilly (LLY).Lilly announced that it would be selling the two lowest doses of its popular injectable obesity drug Zepbound in single-use vials that patients would measure themselves.Lilly said those would be priced at half the cost of the pre-filled vials currently prescribed. In addition, the medicine would be sent through the company's LillyDirect self-pay channel, helping those not eligible for Zepbound's savings program or without insurance coverage to afford it.Hims & Hers Offers Reduced-Priced Copies of Popular DrugsThat was bad news for Hims & Hers Health, which offers direct-to-consumer copycat versions of prescription drugs at reduced prices. In May, it began selling an injectable with the same key ingredient that's in Novo Nordisk's (NVO) popular weight-loss treatments Wegovy and Ozempic. Hims & Hers also said in its recent earnings call that it planned to have one similar to Zepbound "in the near future."Hims & Hers Health shares sank 7% to $15.08 as of 11:15 a.m. ET Tuesday but remain nearly 70% higher year-to-date. Read the original article on Investopedia.
Welcome to Billionaire Club Co LLC, your gateway to a brand-new social media experience! Sign up today and dive into over 10,000 fresh daily articles and videos curated just for your enjoyment. Enjoy the ad free experience, unlimited content interactions, and get that coveted blue check verification—all for just $1 a month!
Account Frozen
Your account is frozen. You can still view content but cannot interact with it.
Please go to your settings to update your account status.
Open Profile Settings